Alzheimer’s Disease remains one of the most pressing challenges in healthcare, with new treatments and research breakthroughs reshaping the landscape of care. This episode dives into the latest advancements, including current medications, clinical trials, and emerging therapies that pharmacists need to know. Stay informed and ready to support patients and caregivers—tune in to expand your expertise and navigate this evolving field with confidence.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
James Hoehns, PharmD, BCPS
Clinical Professor
University of Iowa

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the current treatment options for Alzheimer's Disease.
2. Identify key considerations for pharmacists when counseling patients and caregivers on Alzheimer's Disease management and emerging therapies.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-042-H01-P
Initial release date: 2/24/2025
Expiration date: 2/24/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Stay up-to-date on the latest advancements in antipsychotic medications and how they’re shaping the management of mental health conditions. This episode highlights new formulations, expanded indications, and emerging treatment trends that every pharmacist should know. Don’t miss the chance to enhance your expertise and improve patient care!

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Katelynn Mayberry, PharmD
Clinical Assistant Professor of Pharmacy Practice
Mercer University College of Pharmacy

REFERENCE
The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia. https://psychiatryonline.org/doi/10.1176/appi.ajp.2020.177901

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Recall recent advancements in antipsychotic medications, including new formulations and expanded therapeutic indications.
2. Identify key considerations for pharmacists in optimizing the use of updated antipsychotic treatments to improve patient outcomes.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-031-H01-P
Initial release date: 2/17/2025
Expiration date: 2/17/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Explore the ADA 2025 Diabetes Guideline updates from a different lens – one focused on non-glycemic parameters like cardiovascular health, kidney protection, and weight management. This episode highlights evidence-based recommendations to equip pharmacists with the necessary knowledge to take a more holistic approach to patient care. Listen and discover how to integrate these key updates into your practice to improve outcomes beyond glycemic control.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Justinne Guyton, PharmD, BCACP
Associate Professor of Pharmacy Practice
University of Health Sciences and Pharmacy 

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify three key non-glycemic updates in the ADA 2025 Diabetes Guidelines.
2. Explain the pharmacists role in addressing non-glycemic parameters in diabetes care.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-030-H01-P
Initial release date: 2/10/2025
Expiration date: 2/10/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Learn the essentials of 340B pharmacy and how this program supports access to affordable medications for underserved communities. This episode simplifies key concepts, explains how 340B works, and offers practical guidance for pharmacists just getting started. Tune in to build your confidence and take the first step toward understanding the impact of 340B in your practice!

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Amanda Gaddy, R.Ph.
Co-Founder, COO
Secure340B

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the purpose and structure of the 340B Drug Pricing Program, including its role in expanding access to affordable medications.
2. Identify key responsibilities and considerations for pharmacists participating in 340B programs, including compliance and operational basics.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-020-H04-P
Initial release date: 2/3/2025
Expiration date: 2/3/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Are your student pharmacists or residents struggling with written communication? Join us for a candid conversation with experienced preceptor and former residency director Josh Kinsey, who shares creative, practical strategies to help pharmacy learners enhance their writing—from grammar and spelling to professional documentation and literature analysis. Discover tools, activities, and tips to foster these critical skills while balancing the demands of busy rotations. Tune in and gain insights that will empower you and your learners to succeed!
 
HOST
Kathy Schott, PhD
Vice President, Education & Operations
CEimpact

GUEST
Joshua David Kinsey, PharmD
Vice President, Education
CEimpact

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
 
Learning Objectives
At the end of this course, preceptors will be able to:
1. Identify common barriers that hinder student pharmacists writing development
2. Describe innovative and structured approaches to teach foundational and professional writing skills as part of experiential learning

0.075 CEU/0.75 Hr
UAN: 0107-0000-25-044-H99-P
Initial release date: 1/29/2025
Expiration date: 1/29/2028
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:
Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Stay ahead in stroke prevention with insights from the updated AHA/ASA guidelines, designed to optimize care for at-risk patients. This episode highlights key changes, actionable strategies, and the pharmacist’s role in reducing stroke incidence through evidence-based interventions. Tune in to stay informed and enhance patient outcomes in stroke prevention.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Justinne Guyton, PharmD, BCACP
Associate Professor of Pharmacy Practice
University of Health Sciences and Pharmacy

Reference
2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association
https://www.ahajournals.org/doi/10.1161/STR.0000000000000475

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify three key updates in the AHA/ASA 2024 Stroke Prevention Guideline.
2. Explain the pharmacists role in applying evidence-based strategies for stroke prevention.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-022-H01-P
Initial release date: 1/27/2025
Expiration date: 1/27/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Discover how pharmacists can play a pivotal role in improving the quality of life for patients with cancer through supportive care interventions. This episode explores practical strategies for managing side effects, enhancing adherence, and addressing the unique needs of oncology patients. Don’t miss this chance to expand your impact—listen now and learn how to provide compassionate, evidence-based care to your patients.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Olivia Fahey, PharmD, BCOP
Cancer Care Education Pharmacist
The University of Kansas Cancer Center
 
Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1.  Describe common supportive care needs for patients with cancer, including management of side effects and comorbidities.
2. Identify evidence-based strategies pharmacists can use to enhance medication adherence and improve the overall quality of life for patients with cancer.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-021-H01-P
Initial release date: 1/20/2025
Expiration date: 1/20/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Explore the emerging role of psychedelics in pharmacy practice and their potential to transform mental health treatment. This episode dives into the science, safety, and regulatory considerations pharmacists need to know as these therapies move toward mainstream use. Don’t miss this opportunity to stay ahead of the curve—tune in and expand your understanding of this groundbreaking area of care!

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Colby Burns, PharmD
Clinical Pharmacist, CHAS Healthcare
President, Psychedelic Pharmacist Association
Owner/Host, Neural Pharm Online Platform and Podcast

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the current evidence and therapeutic potential of psychedelics in treating mental health conditions.
2. Identify key safety, regulatory, and clinical considerations for pharmacists as psychedelics become integrated into patient care.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-023-H01-P
Initial release date: 1/13/2025
Expiration date: 1/13/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

The rise of electronic tobacco use, especially among young adults, poses new challenges for public health and pharmacy practice. This episode highlights the pharmacist's role in addressing vaping trends through patient education, harm reduction strategies, and community outreach. Tune in to learn how you can make a meaningful impact in curbing this growing epidemic.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Francis M. Vitale, MA
National Director
Pharmacy Partnership for Tobacco Cessation

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the current trends and health risks associated with electronic tobacco use.
2. Identify evidence-based strategies pharmacists can use to address vaping in their practice.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-015-H04-P
Initial release date: 1/6/2025
Expiration date: 2/6/2026
Additional CPE details can be found here.

LOOKING FOR MORE SMOKING CESSATION TRAINING? Click here to check out our advanced training course!

Follow CEimpact on Social Media:
LinkedIn
Instagram

Medications play a crucial role in managing symptoms and enhancing the quality of life for individuals with autism spectrum disorders, yet their use requires careful consideration and specialized knowledge. Pharmacists are essential in navigating the nuances of these therapies, from dosing adjustments to monitoring for side effects and interactions. Join us to expand your expertise in supporting this unique patient population through informed, compassionate care.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Jena Quinn, PharmD
CEO
Perfecting Peds

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify commonly used medications for managing symptoms in autism spectrum disorders and their primary therapeutic effects.
2. Describe key considerations for dosing, side effects, and drug interactions in medications prescribed for autism spectrum disorders.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-319-H01-P
Initial release date: 12/30/2024
Expiration date: 12/30/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram